Ian Karp
Head of Investor RelationsMr. Ian Karp, MBA, served as Senior Vice President of Investor Relations and Corporate Communications at Intellia Therapeutics, Inc. since July 2021 until October 2024. He serves as Head of Investor Relations at Collegium Pharmaceutical, Inc. He served as a Senior Vice President of Investor & Public Relations at Karyopharm Therapeutics Inc. since 2020 until 2021. He had been a Vice President of Investor and Public Relations at Karyopharm Therapeutics Inc. since July 2018 until 2020. He leads all of the Karyopharm Therapeutics Inc.’s corporate communications activities, including corporate visibility, financial communications and media and investor relations. Mr. Karp brings over 20 years of investor relations, corporate development and commercial experience and has successfully led global teams in achieving key corporate communications objectives, including in the areas of oncology and orphan diseases. Prior to joining Karyopharm Therapeutics Inc., Mr. Karp held several roles with increasing responsibility at Shire plc, culminating in his role as Vice President and Head of Global Investor Relations. In addition, he previously served as Shire’s Head of Commercial Assessment and played a critical role in Shire’s corporate acquisition strategy between 2012-2016. Before joining Shire, he served as Sr. Director for Global Marketing, Emerging Oncology Brands at MedImmune, an AstraZeneca company. In this role, he served as MedImmune’s commercial lead for clinical and preclinical programs across 20+ cancer indications in both solid tumors and hematological malignancies. Prior to his time at MedImmune, he held positions at Johnson & Johnson’s Centocor division as well as at Pharmacia (now part of Pfizer) in a variety of sales and marketing roles, including field reimbursement support for Pharmacia’s cancer franchise. Mr. Karp holds a Bachelor of Science degree in biology from Emory University and an M.B.A. from Rutgers Business School with a concentration in pharmaceutical management.
Positions
- Company NameCollegium Pharmaceutical, Inc.Stock CodeCOLLPositionHead of Investor RelationsColleagues
- VKVikram KarnaniCEO, President & Director
- GSGino SantiniIndependent Chairman
- CTColleen TupperExecutive VP & CFO
- DDDavid DieterExecutive VP, General Counsel & Corporate Secretary
- TBThomas B. SmithExecutive VP & Chief Medical Officer
- GGGaren G. BohlinIndependent Director
- RJRita J. Balice-GordonIndependent Director
- NSNancy S. LurkerIndependent Director
